These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17555618)

  • 21. Application of Monte Carlo simulation-based photon migration for enhanced understanding of near-infrared (NIR) diffuse reflectance. Part I: Depth of penetration in pharmaceutical materials.
    Shi Z; Anderson CA
    J Pharm Sci; 2010 May; 99(5):2399-412. PubMed ID: 19967783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of electrostatic charging on pharmaceutical powder blending homogeneity.
    Pu Y; Mazumder M; Cooney C
    J Pharm Sci; 2009 Jul; 98(7):2412-21. PubMed ID: 18855912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation.
    El-Hagrasy AS; D'Amico F; Drennen JK
    J Pharm Sci; 2006 Feb; 95(2):392-406. PubMed ID: 16381014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of drug dissolution profiles from tablets using NIR diffuse reflectance spectroscopy: a rapid and nondestructive method.
    Freitas MP; Sabadin A; Silva LM; Giannotti FM; do Couto DA; Tonhi E; Medeiros RS; Coco GL; Russo VF; Martins JA
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):17-21. PubMed ID: 15935597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of size and density of particles on flow properties of granules.
    Czarnecki W; Szumiło M; Wasik D
    Acta Pol Pharm; 2009; 66(5):553-61. PubMed ID: 19894652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of pharmaceutical powder blends by NIR chemical imaging.
    Ma H; Anderson CA
    J Pharm Sci; 2008 Aug; 97(8):3305-20. PubMed ID: 17948913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIR chemical imaging to guide/support BMS-561389 tablet formulation development.
    Hilden LR; Pommier CJ; Badawy SI; Friedman EM
    Int J Pharm; 2008 Apr; 353(1-2):283-90. PubMed ID: 18182257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders.
    Kwan CC; Chen YQ; Ding YL; Papadopoulos DG; Bentham AC; Ghadiri M
    Eur J Pharm Sci; 2004 Dec; 23(4-5):327-36. PubMed ID: 15567285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
    Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
    Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flowability characterisation of drug-excipient blends using a novel powder avalanching method.
    Nalluri VR; Kuentz M
    Eur J Pharm Biopharm; 2010 Feb; 74(2):388-96. PubMed ID: 19796683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Miniaturization of powder dissolution measurement and estimation of particle size.
    Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
    Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-comparing common calibration approaches.
    Ravn C; Skibsted E; Bro R
    J Pharm Biomed Anal; 2008 Nov; 48(3):554-61. PubMed ID: 18774667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of powder processing on performance of fenofibrate formulations.
    Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of near infrared and microwave resonance sensors for at-line moisture determination in powders and tablets.
    Corredor CC; Bu D; Both D
    Anal Chim Acta; 2011 Jun; 696(1-2):84-93. PubMed ID: 21621036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process.
    De Beer TR; Bodson C; Dejaegher B; Walczak B; Vercruysse P; Burggraeve A; Lemos A; Delattre L; Heyden YV; Remon JP; Vervaet C; Baeyens WR
    J Pharm Biomed Anal; 2008 Nov; 48(3):772-9. PubMed ID: 18799281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.
    Otsuka M; Kato F; Matsuda Y; Ozaki Y
    AAPS PharmSciTech; 2003; 4(2):E19. PubMed ID: 12916901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-destructive determination of metronidazole powder by using artificial neural networks on short-wavelength NIR spectroscopy.
    Zhao L; Dou Y; Mi H; Ren M; Ren Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Apr; 66(4-5):1327-32. PubMed ID: 16920000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near-infrared spectral imaging for quality assurance of pharmaceutical products: analysis of tablets to assess powder blend homogeneity.
    Lyon RC; Lester DS; Lewis EN; Lee E; Yu LX; Jefferson EH; Hussain AS
    AAPS PharmSciTech; 2002; 3(3):E17. PubMed ID: 12916932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending: Part II: Qualitative near-infrared models for prediction of blend homogeneity.
    El-Hagrasy AS; Delgado-Lopez M; Drennen JK
    J Pharm Sci; 2006 Feb; 95(2):407-21. PubMed ID: 16380974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.